A paradigm shift in U.S. breast reconstruction: Part 2. the influence of changing mastectomy patterns on reconstructive rate and method

Plastic and Reconstructive Surgery

Volumn 131, Issue 3, 2013, Pages

  Cemal, Yeliz ^a   Albornoz, Claudia R ^a   Disa, Joseph J ^a   Mccarthy, Colleen M ^a   Mehrara, Babak J ^a   Pusic, Andrea L ^a   Cordeiro, Peter G ^a   Matros, Evan ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST RECONSTRUCTION; FEMALE; HUMAN; LONGITUDINAL STUDY; MASTECTOMY; METHODOLOGY; MIDDLE AGED; STATISTICS; TIME; UNITED STATES;

ADULT; FEMALE; HUMANS; LONGITUDINAL STUDIES; MAMMAPLASTY; MASTECTOMY; MIDDLE AGED; TIME FACTORS; UNITED STATES;

MLCS; MLOWN;

EID: 84875049167     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e31827cf576     Document Type: Article

References (26)

1. Reuben BC, Manwaring J, Neumayer LA. Recent trends and predictors in immediate breast reconstruction after mastectomy in the United States. Am J Surg. 2009;198:237-243.
2. Christian CK, Niland J, Edge SB, et al. A multi-institutional analysis of the socioeconomic determinants of breast reconstruction: A study of the National Comprehensive Cancer Network. Ann Surg. 2006;243:241-249.
3. Albornoz CR, Bach PB, Mehrara BJ, et al. A paradigm shift in U.S. breast reconstruction: Increasing rates of implant use. Plast Reconstr Surg. 2013;131:15-23.
4. Tuttle TM, Habermann EB, Grund EH, Morris TJ, Virnig BA. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: A trend toward more aggressive surgical treatment. J Clin Oncol. 2007;25:5203-5209.
5. Tuttle TM, Jarosek S, Habermann EB, et al. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol. 2009;27:1362-1367.
6. Yao K, Stewart AK, Winchester DJ, Winchester DP. Trends in contralateral prophylactic mastectomy for unilateral cancer: A report from the National Cancer Data Base, 1998-2007. Ann Surg Oncol. 2010;17:2554-2562.
7. Habermann EB, Abbott A, Parsons HM, Virnig BA, Al-Refaie WB, Tuttle TM. Are mastectomy rates really increasing in the United States? J Clin Oncol. 2010;28:3437-3441.
8. Healthcare Cost and Utilization Project (HCUP). HCUP Nationwide Inpatient Sample (NIS). Agency for Healthcare Research and Quality Research, Rockville, Md. Available at: http://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed July 1, 2011.
9. Hislop TG, Elwood JM, Coldman AJ, Spinelli JJ, Worth AJ, Ellison LG. Second primary cancers of the breast: Incidence and risk factors. Br J Cancer 1984;49:79-85.
10. Lehman CD, Gatsonis C, Kuhl CK, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007;356:1295-1303.
11. Vaittinen P, Hemminki K. Risk factors and age-incidence relationships for contralateral breast cancer. Int J Cancer 2000;88:998-1002.
12. Graeser MK, Engel C, Rhiem K, et al. Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers. J Clin Oncol. 2009;27:5887-5892.
13. Wood WC. Should the use of contralateral prophylactic mastectomy be increasing as it is? Breast 2009;18(Suppl 3):S93-S95.
14. Society of Surgical Oncology. Position statement on prophylactic mastectomy. 2007. Available at: http://www.surgonc. org/practice-policy/ practice-management/consensusstatements/prophylactic-mastectomy.aspx. Accessed July 1, 2012.
15. Cigna. Cigna medical coverage policy. Available at: http://www.cigna.com/ assets/docs/health-care-professionals/coverage-positions/mm-0029- coveragepositioncriteria-prophylactic-mastectomy.pdf. 2011; Accessed July 1, 2012.
16. Medicaid. Medical and Health Choice Clinical Coverage Policy No: 1A-12. Available at: http://www.ncdhhs.gov/dma/mp/1a12.pdf. 2012. Accessed July 1, 2012.
17. Han E, Johnson N, Glissmeyer M, et al. Increasing incidence of bilateral mastectomies: The patient perspective. Am J Surg. 2011;201:615-618.
18. Arrington AK, Jarosek SL, Virnig BA, Haberman EB, Tuttle TM. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol. 2009;16:2697-2704.
19. Jones NB, Wilson J, Kotur L, Stephens J, Farrar WB, Agnese DM. Contralateral prophylactic mastectomy for unilateral breast cancer: An increasing trend at a single institution. Ann Surg Oncol. 2009;16:2691-2696.
20. King TA, Sakr R, Patil S, et al. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol. 2011;29:2158-2164.
21. Sorbero ME, Dick AW, Beckjord EB, Ahrendt G. Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy. Ann Surg Oncol. 2009;16:1597-1605.
22. Morrow M, Harris Jr. More mastectomies: Is this what patients really want? J Clin Oncol. 2009;27:4038-4040.
23. Tuttle TM, Abbott A, Arrington A, Rueth N. The increasing use of prophylactic mastectomy in the prevention of breast cancer. Curr Oncol Rep. 2010;12:16-21.
24. Guth U, Myrick ME, Viehl CT, Weber WP, Lardi AM, Schmid SM. Increasing rates of contralateral prophylactic mastectomy: A trend made in USÄ Eur J Surg Oncol. 2012;38:296-301.
25. U.S. Food and Drug Administration. Regulatory history of breast implants in the U.S. Available at: http://www.fda. gov/MedicalDevices/ ProductsandMedicalProcedures/ImplantsandProsthetics/BreastImplants/ucm064461. htm. Accessed November 1, 2011.
26. McLaughlin CC, Lillquist PP, Edge SB. Surveillance of prophylactic mastectomy: Trends in use from 1995 through 2005. Cancer 2009;115:5404-5412.